Amesite, a leading developer of AI-powered enterprise solutions, announced 63% revenue growth for its NurseMagic platform following the launch of its census-based Enterprise subscription model on July 14, 2025. Enterprise sales have now surpassed B2C sales, reflecting rising demand from post-acute care providers seeking scalable, compliant technology designed to deliver full reimbursement rates. Amesite also announces the launch of its AI-powered automated form fill for required government forms.
Health Technology Insights: IQVIA Launches Next-Gen Clinical Trial Financial Suite
“We’re no longer just selling to employees – we’re selling to serve every patient in the system and help organizations leverage AI technology as a true competitive advantage,” said Brandon Owens, VP of Sales at Amesite. “That changes the game. The total addressable market is exponentially larger, and our pricing reflects the performance of our solution. Customers are choosing NurseMagic Enterprise to scale operations without adding staff, addressing one of the greatest costs in healthcare.”
The announcement comes as the Centers for Medicare & Medicaid Services (CMS) prepares to mandate the Hospice Outcomes and Patient Evaluation (HOPE) assessment this October – a regulatory overhaul expected to significantly increase documentation burden per patient and strain already thin hospice staffing cohort. Amesite’s AI-powered HOPE automation solution, within NurseMagic™ Enterprise, is designed to enable organizations to auto-populate complex forms, cut administrative time, and assure full reimbursements.
Health Technology Insights: GE Healthcare to Acquire Icometrix for Brain MRI Solutions
“The government’s scrutiny of documentation is intensifying, and many organizations are unprepared,” said Kalie Wortinger, Senior Engineering Manager at Amesite. “With the HOPE requirement looming, providers are seeking a solution that enables compliant, reimbursable submission of documentation. NurseMagic™ Enterprise has modular intelligence that enables our customers to document compliantly, and to be fully reimbursed for the crucial work they do.”
“We’ve taken an entirely different approach from traditional EMR vendors,” said Dr. Ann Marie Sastry, CEO of Amesite. “Our platform reimagines how post-acute care organizations handle regulatory requirements, enabling them to leverage our AI-powered tools to scale operations without adding staff. We specifically designed our solution to be an essential edge for customers, in a highly competitive, and demographically inevitable, market.”
The post-acute care market is growing faster than the acute care market at a CAGR of 8%.
Health Technology Insights: Health Technology Insights: Latest News And Innovations – Roundup 10 September 2025
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – GlobeNewswire
